ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $424,554 | -14.0% | 23,276 | -2.5% | 0.01% | -26.3% |
| Q4 2022 | $493,507 | -35.0% | 23,864 | -18.1% | 0.02% | -24.0% |
| Q3 2022 | $759,000 | -6.9% | 29,153 | -9.4% | 0.02% | +4.2% |
| Q2 2022 | $815,000 | -11.3% | 32,184 | +10.5% | 0.02% | 0.0% |
| Q1 2022 | $919,000 | -6.4% | 29,125 | +20.0% | 0.02% | -7.7% |
| Q4 2021 | $982,000 | -51.9% | 24,270 | -58.6% | 0.03% | -58.1% |
| Q3 2021 | $2,043,000 | +18.5% | 58,581 | -6.7% | 0.06% | +19.2% |
| Q2 2021 | $1,724,000 | +11.4% | 62,765 | +13.8% | 0.05% | 0.0% |
| Q1 2021 | $1,548,000 | +7.8% | 55,144 | -0.3% | 0.05% | -10.3% |
| Q4 2020 | $1,436,000 | +86.3% | 55,334 | +23.0% | 0.06% | +52.6% |
| Q3 2020 | $771,000 | -35.3% | 44,978 | -6.7% | 0.04% | -39.7% |
| Q2 2020 | $1,192,000 | -41.6% | 48,200 | -67.1% | 0.06% | -21.2% |
| Q3 2018 | $2,041,000 | +6.8% | 146,384 | -6.2% | 0.08% | +5.3% |
| Q2 2018 | $1,911,000 | – | 156,139 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |